Genext Genomics Private Limited, a active private limited company, was established on 24 January 2011 in Nagpur, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73100MH2011PTC212683. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Its leadership includes Manjiri Sandeep Singh (Director), Supriya Kashikar (Whole-Time Director), Ashwin Ravi Kashikar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 103, Abhyankar Nagar, Zenda Chowk, Nagpur, Maharashtra, 440010.
U73100MH2011PTC212683
212683
24 January 2011
₹3.00 M
₹3.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Genext Genomics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manjiri Sandeep Singh | Director | 24 Jan 2011 | Current |
| Supriya Kashikar | Whole-Time Director | 16 Feb 2018 | Current |
| Ashwin Ravi Kashikar | Director | 24 Jan 2011 | Current |
| Shivali Vaibhav Kashikar | Director | 24 Jan 2011 | Current |
| Ravi Madan Kashikar | Director | 24 Jan 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genext Genomics Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.12% increase. The company also saw a slight improvement in profitability, with a 2.68% increase in profit. The company's net worth dipped by a decrease of 4.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Genext Genomics had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Genext Genomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Genext Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genext Genomics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Genext Genomics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Genext Genomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Supriya Kashikar was appointed as a Whole-time director was appointed as a Whole-time director on 16 Feb 2018 & has been associated with this company since 7 years 9 months . was documented.
Progress on Manjiri Sandeep Singh was appointed as a Director was appointed as a Director on 24 Jan 2011 & has been associated with this company since 14 years 10 months . was documented.
Ashwin Ravi Kashikar was appointed as a Director was appointed as a Director on 24 Jan 2011 & has been associated with this company since 14 years 10 months . was recorded as a recent event.
The activity Shivali Vaibhav Kashikar was appointed as a Director was appointed as a Director on 24 Jan 2011 & has been associated with this company since 14 years 10 months . was completed.
The CIN of Genext Genomics Private Limited is U73100MH2011PTC212683.
Genext Genomics Private Limited is headquartered at 103, Abhyankar Nagar, Zenda Chowk, Nagpur, Maharashtra, 440010.
Genext Genomics Private Limited was incorporated on 24 January 2011.
The current directors of Genext Genomics Private Limited are
The primary industry of Genext Genomics Private Limited is Professional, Scientific And Technical.
Genext Genomics Private Limited is unlisted.
The authorized capital of Genext Genomics Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Genext Genomics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX